Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

The research team, led by Darrell Kotton, MD, and Anthony Hollenberg, MD, has developed a successful protocol for producing ...

Follicular lymphoma is a diverse disease ... Finally, hematopoietic stem cell transplantation (both autologous and allogeneic) remains a useful treatment strategy, although the optimal timing ...

Faia and colleagues reported that duvelisib exhibited growth inhibitory activity in a variety of malignant hematologic cell lines, including DOHH-2 and WSU-NHL, both of which represent transformed FL.

Incyte’s previously disclosed phase 3 win in relapsed or refract | In the phase 3 inMIND study, Monjuvi—added to Bristol ...

One of the most common forms of Non-Hodgkin's lymphoma is follicular lymphoma, a slow growing blood cancer that affects your immune system. It occurs when infection fighting white cells called B ...

But only one follicle – the largest and most well-developed – usually reaches ovulation, where the follicle ruptures like a ...

Late-breaking data presentation at ASH will feature results from the Phase 3 inMIND study evaluating tafasitamab in ...

At the 42nd Annual Chemotherapy Foundation Symposium, Erin Mulvey, MD, discussed the significant progress being made in the ...

The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...